204 filings
Page 2 of 11
8-K
atm9ehl
3 Jun 09
Other Events
12:00am
8-K
vg03328qwe
19 May 09
Osi Pharmaceuticals Provides Update on Diabetes and Obesity Clinical Programs
12:00am
8-K
9bavpfrd
29 Apr 09
OSI Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
12:00am
8-K
zdb1a8zjmnbvjbp
24 Apr 09
Other Events
12:00am
8-K
ub4oqo
16 Apr 09
Other Events
12:00am
8-K
aim397jh5o
24 Mar 09
Other Events
12:00am
8-K
8ffcxe2h0h oo
4 Mar 09
OSI Pharmaceuticals Response to Initial Non-Final Office Action by U.S. Patent and Trademark Office
12:00am
8-K
jdfbxpehz frr9
19 Feb 09
OSI Pharmaceuticals, Inc. Announces Year End 2008 Financial Results
12:00am
8-K
jyath0k
12 Feb 09
OSI Pharmaceuticals Announces Notification of ANDA Filing for Tarceva
12:00am
8-K
fgzfxr33y
4 Feb 09
Other Events
12:00am
8-K
ocvhrr1 tpaj
16 Jan 09
Other Events
12:00am
8-K
zeegjg 8t6wqd7183m5u
18 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
umdj9ri58r3ut l6rugs
16 Dec 08
OSI Pharmaceuticals Announces the Appointment of Mr. Pierre Legault as Executive Vice President and Chief Financial Officer
12:00am
8-K
tmufyjkp gzbv325t
4 Dec 08
Regulation FD Disclosure
12:00am
8-K
z1j72m2a4ta9g0lg9caq
21 Nov 08
Entry into a Material Definitive Agreement
12:00am
8-K
1zwbu8gs87
12 Nov 08
Phase Iii Study (Saturn) Showed Tarceva Improved Progression-free Survival As a First-line Maintenance Therapy for Advanced Non-small Cell Lung Cancer
12:00am
8-K
4vu50 pff8znf2n
23 Oct 08
OSI Pharmaceuticals Announces Third Quarter 2008 Financial Results
12:00am
8-K
pzp440t
21 Oct 08
Other Events
12:00am
8-K
l2igjjfmwqygidr vdm2
14 Oct 08
Other Events
12:00am
8-K
5wmlufw8fuxkdktvxvs
7 Oct 08
Other Events
12:00am